Etgar Levy-Nissenbaum

Etgar Levy-Nissenbaum's work experience includes several key roles in the pharmaceutical and biotech industries. In 2000, they began their career as a PhD candidate at Tel Hashomer. Etgar then went on to work as a research fellow at both the Massachusetts Institute of Technology and Harvard Medical School from 2005 to 2007. In 2007, they joined BioLineRx as a manager of drug development before working their way up to senior director and senior manager. During their time at BioLineRx, they played a crucial role in the development and commercialization of a drug-device product. In 2014, Levy-Nissenbaum became the CEO and founder of Skin-View, a position they held until 2017. From 2015 to 2018, they worked at Teva Pharmaceuticals as a director of new technologies application, where they supported global R&D groups and spearheaded the development of cutting-edge platform technologies. Most recently, in 2018, Etgar Levy-Nissenbaum joined Lycored as the SVP of global R&D.

Etgar Levy-Nissenbaum has an extensive education history. Etgar completed their Bachelor of Science degree in Biology at Tel Aviv University from 1998 to 2000. Etgar then pursued a Master of Science degree in Molecular Biology and Human Genetics at Tel Aviv University, which they completed from 2000 to 2002. Continuing their academic journey, Levy-Nissenbaum obtained their Ph.D. in Molecular Biology and Human Genetics from Tel Aviv University, where they studied from 2002 to 2005. Etgar further expanded their expertise through two postdoctoral positions. From 2005 to 2007, they conducted research in the field of Cancer at Harvard Medical School. During the same period, they also pursued a postdoctoral position in Nanotechnology at Massachusetts Institute of Technology.